The Valley Desk

NCT06261957 · Interventional trial

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Overall registry status Completed

Phase 3

Conditions Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov